Multi-Scale glycemic variability: A link to gray matter atrophy and cognitive decline in type 2 diabetes

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cui, Xingran ^a   Abduljalil, Amir ^b   Manor, Brad D ^a,c   Peng, Chung Kang ^a,d   Novak, Vera ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Hebrew Senior Life Institute for Aging Research   (United States)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; FUNCTIONAL ASSESSMENT; GLYCEMIC CONTROL; GRAY MATTER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIMBIC SYSTEM; MALE; MENTAL PERFORMANCE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MULTI SCALE GLYCEMIC VARIABILITY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATROPHY; BLOOD GLUCOSE; BRAIN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; COGNITION DISORDERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; RISK FACTORS;

EID: 84899826730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086284     Document Type: Article

References (47)

1. Launer LJ (2006) Diabetes and brain aging: epidemiologic evidence. Curr Diab Rep 5: 59-63.
2. Strachan MW, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7: 108-114.
3. Last D, Alsop DC, Abduljalil AM, Marquis RP, de Bazelaire C, et al. (2007) Global and regional effects of type 2 diabetes mellitus on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 30: 1193-1199. (Pubitemid 46684647)
4. Novak V, Zhao P, Manor B, Sejdic E, Alsop D, et al. (2011) Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care 34: 2438-2441.
5. Strachan MW, Price JF, Frier BM (2008) Diabetes, cognitive impairment, and dementia. BMJ 336: 6.
6. Strachan MW, Reynolds RM, Frier BM, Mitchell RJ, Price JF (2008) The relationship between type 2 diabetes and dementia. Br Med Bull 88: 131-146.
7. Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, et al. (2007) The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol 99: 112i-122i.
8. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, et al.(2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32: 221-226.
9. Shannahoff-Khalsa DS, Kennedy B, Yates FE, Ziegler MG (1997) Low-frequency ultradian insulin rhythms are coupled to cardiovascular, autonomic, and neuroendocrine rhythms. Am J Physiol 272: R962-R968.
10. Kalsbeek A, Yi CX, La Fleur SE, Fliers E (2010) The hypothalamic clock and its control of glucose homeostasis. Trends Endocrinol Metab 21: 402-410.
11. Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, et al. (1991) Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 88: 934-942.
12. Van Cauter E, Polonsky KS, Scheen AJ (1997). Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 18: 716-738. (Pubitemid 27435542)
13. Scheen AJ, Sturis J, Polonsky KS, Van CE (1996) Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging. Diabetologia 39: 564-572. (Pubitemid 26135459)
14. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML (1989) Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 257: E6-14.
15. Schaefer A, Simon C, Viola AU, Piquard F, Geny B, et al. (2003) L-arginine: an ultradian-regulated substrate coupled with insulin oscillations in healthy volunteers. Diabetes Care 26: 168-171. (Pubitemid 36929011)
16. Simon C, Brandenberger G (2002) Ultradian oscillations of insulin secretion in humans. Diabetes 51 Suppl 1: S258-S261. (Pubitemid 34761525)
17. Simon C, Brandenberger G, Follenius M, Schlienger JL (1991) Alteration in the temporal organisation of insulin secretion in type 2 (non-insulin- dependent) diabetic patients under continuous enteral nutrition. Diabetologia 34: 435-440.
18. Hajjar I, Zhao P, Alsop D, Abduljalil A, Selim M, et al. (2009) Association of Blood Pressure Elevation and Nocturnal Dipping With Brain Atrophy, Perfusion and Functional Measures in Stroke and Nonstroke Individuals. Am J Hypertens.
19. Kolopp M, Bicakova-Rocher A, Reinberg A, Drouin P, Mejean L, et al. (1986) Ultradian, circadian and circannual rhythms of blood glucose and injected insulins documented in six self-controlled adult diabetics. Chronobiol Int 3: 265-280. (Pubitemid 17219106)
20. Maury E, Ramsey KM, Bass J (2010) Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res 106: 447-462.
21. Siegelaar SE, Hickmann M, Hoekstra JB, Holleman F, DeVries JH (2011) The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis. Crit Care 15: R205.
22. Huang NE, Shen Z, Long SR, Wu MC, Shih EH, et al. (1998) The empirical mode decomposition method and the Hilbert spectrum for non-stationary time series analysis. Proc Roy Soc London A454: 903-995. (Pubitemid 128733183)
23. Wu Z, Huang NE (2009) Ensemble Empirical Mode Decomposition: a noise-assisted data analysis method. Advances in Adaptive Data Analysis 1: 1-41.
24. Cui X, Peng CK, Costa MD, Weiss A, Goldberger AL, et al. (2014) Development of a new approach to quantifying stepping stability using ensemble empirical mode decomposition. Gait Posture 39: 495-500.
25. Hajjar I, Zhao P, Alsop D, Novak V (2010) Hypertension and cerebral vasoreactivity: a continuous arterial spin labeling magnetic resonance imaging study. Hypertension 56: 859-864.
26. Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, et al. (2011) Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96: 2968-2979.
27. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, et al. (2004) Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther 6: 105-113. (Pubitemid 38445735)
28. Shapiro A, Benedict R, Schretlen D, Brandt J (1999) Construct and concurrent validity of the Hopkins Verbal Learning Test-Revised. Clinical Neuropsychologist 13: 348-358. (Pubitemid 30040145)
29. Benton AL, Hamsher K(1976) Multilingual Aphasia Examination. University of Iowa, Iowa City.
30. Slotkin J, Kallen M, Griffith J, Magasi S, Salsman J, et al. (2012) NIH Toolbox Cognition Battery Composite Scores Technical Manual.
31. D'Agostino E, Maes F, Vandermeulen D, Suetens P (2004) Non-rigid atlas-to-image registration by minimization of class-conditional image entropy. 745-753.
32. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, et al. (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644-655.
33. Mager DE, Abernethy DR (2007) Use of wavelet and fast Fourier transforms in pharmacodynamics. J Pharmacol Exp Ther 321: 423-430. (Pubitemid 46624483)
34. Gyaw TA, Ray SR (1994) The wavelet transform as a tool for recognition of biosignals. Biomed Sci Instrum 30: 63-68.
35. Lo MT, Hu K, Liu Y, Peng CK, Novak V (2008) Multimodal Pressure Flow Analysis: Application of Hilbert Huang Transform in Cerebral Blood Flow Regulation. EURASIP J Appl Signal Processing 2008: 785243.
36. Lo MT, Novak V, Peng CK, Liu Y, Hu K (2009) Nonlinear phase interaction between nonstationary signals: A comparison study of methods based on Hilbert-Huang and Fourier transforms, "published in Physical Review E 79, 061924 (2009. Phys Rev E Stat Nonlin Soft Matter Phys 79: 061924.
37. Kreier F, Kalsbeek A, Sauerwein HP, Fliers E, Romijn JA, et al. (2007) "Diabetes of the elderly" and type 2 diabetes in younger patients: possible role of the biological clock. Exp Gerontol 42: 22-27. (Pubitemid 44937831)
38. Kalsbeek A, Scheer FA, Perreau-Lenz S, La Fleur SE, Yi CX, et al. (2011) Circadian disruption and SCN control of energy metabolism. FEBS Lett 585: 1412-1426.
39. Manor B, Newton E, Abduljalil A, Novak V. (2012) The relationship between brain volume and walking outcomes in older adutls with diabetci peripheral neuropathy. Diabetes Care 35:1907-1912.
40. Kohnert KD, Heinke P, Vogt L, Zander E, Fritzsche G, et al. (2011) Reduced glucose variability is associated with improved quality of glycemic control in patients with type 2 diabetes: a 12-month observational study. J Endocrinol Metab 1: 64-72.
41. Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA (2006) Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29(3): 560-565. (Pubitemid 44115354)
42. Fontbonne A, Berr C, Ducimetière P, Alpérovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24(2): 366-370. (Pubitemid 32119140)
43. Last D, Alsop DC, Abduljalil AM, Marquis RP, de Bazelaire C, et al. (2007) Global and regional effects of type 2 diabetes mellitus on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 30:1193-1199. (Pubitemid 46684647)
44. Novak V, Haertle M, Zhao P, Hu K, Munshi M, et al. (2009) White matter hyperintensities and dynamics of postural control. Magnetic Resonance Imaging 27:752-759.
45. Tiehuis AM, Vincken KL, van den Berg E, Hendrikse J, Manschot SM, et al. (2008) Cerebral perfusion in relation to cognitive function and type 2 diabetes. Diabetologia 51:1321-1326.
46. Brownlee M (2006). The pathobiology of diabetic complications. Diabetes 54:1615-1625.
47. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, et al. (2004). Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53(2): 474-81. (Pubitemid 38174565)